Both are FDA-approved injections that suppress appetite, slow stomach emptying, and support long-term weight management
Expanded Approval for Long-Lasting Birth Control Implant Organons Nexplanon (etonogestrel), a rod-shaped contraceptive device that is implanted just under the skin in the upper arm, received FDA approval that allows for extending its use for up to five-years instead of just three
Retatrutide Safety Data: Gastrointestinal events: 34% incidence (mild-moderate) Hypoglycemia risk: 2.1% severe events Injection site reactions: 8.7% Cardiovascular events: 0.9% Pancreatitis risk: 0.2% Semaglutide Safety Data: Gastrointestinal events: 44% incidence (mild-moderate) Hypoglycemia risk: 3.2% severe events Injection site reactions: 12.4% Cardiovascular events: 1.2% Pancreatitis risk: 0.3% The reduced gastrointestinal adverse event profile of retatrutide potentially results from its balanced receptor activation approach, minimizing excessive GLP-1 stimulation while maintaining therapeutic efficacy.If you need peptide APIs with improved tolerability profiles for sensitive patient populations, then retatrutide offers enhanced safety characteristics compared to traditional GLP-1 agonists
McGlory C, van Vliet S, Stokes T, Mittendorfer B, Phillips SM
The facility will produce active pharmaceutical ingredients for small molecule and peptide medicines, including orforglipron, Lilly's oral GLP-1 candidate in late-stage development
Another key question is whether psychiatric effects are direct or secondary to metabolic improvements
